$Tempus AI(TEM)$ Big buy.
The current price fall is due to post-IPO volatility: executives selling shares to cover tax obligations. This is a pre-planned and routine transaction. It does not signal a lack of confidence in the company's future prospects.
TEM continues to show strong growth prospects, driven by key initiatives like Medicare approval, acquisitions (e.g., Ambry Genetics), and a rapidly growing healthcare AI market.
Accumulate and hold till at least Q1 FY25.
Support lines: 31.06, 23.01
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments